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Introduction: Paraneoplastic syndromes are disorders associated with clinical signs and symptoms caused by
substances produced by malignant disease and are not directly related to the physical effects of a primary or
metastatic tumor. We describe a patient with gastrointestinal stromal tumor of the stomach accompanied by
nephrotic syndrome as paraneoplastic syndrome in whom symptomatic treatment was ineffective. Nephrotic
syndrome caused by gastrointestinal stromal tumors is quite rare, and to the best of our knowledge this is the first
time that such a case has been documented.
Case presentation: We describe a 69-year-old Asian woman with a gastrointestinal stromal tumor of the stomach
accompanied by paraneoplastic syndrome. The patient had severe hypoalbuminemia and proteinuria, which were
apparently attributed to a gastrointestinal stromal tumor. After preoperative treatment for hypoalbuminemia, the
tumor was resected and nephrotic syndrome improved. Two years after her operation, she is still alive with neither
tumor recurrence nor nephrotic syndrome.
Conclusion: Patients with refractory nephrotic syndrome caused by a malignant tumor should be treated
aggressively, even if they are in poor general condition. Otherwise, the opportunity for potentially curative surgery
may be missed.
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Paraneoplastic syndrome (PNS) is a disorder or symp-
tom caused by cancer or a reaction to a tumor, but is
not due to the local presence of cancer cells [1,2]. PNS
can resolve after complete tumor resection or a response
to chemotherapy and recur in association with tumor re-
currence. Clinical manifestations are mediated by hor-
mones or cytokines excreted by tumor cells or by an
immune response against the tumor [3].
The signs and symptoms of PNS are diverse, but com-
mon features include neuropathy, skin disease, and
nephrotic syndrome. Peripheral neuropathy is one of the
most frequent types of PNS of the nervous system and is* Correspondence: mido-tky@umin.ac.jp
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unless otherwise stated.usually associated with slight loss of muscle strength,
hypoesthesia, and areflexia [4]. Itching paresthesia is the
most common cutaneous symptom, and such symptoms
may improve after treatment of the primary disease [1].
PNS is common among middle-aged and elderly patients
who harbor cancers of the lung, breast, or ovaries, or
lymphoma as the primary disease [5].
We describe a patient with gastrointestinal stromal
tumor (GIST) of the stomach accompanied by nephrotic
syndrome as PNS in whom symptomatic treatment was
ineffective, but clinical remission was obtained after an
operation. To the best of our knowledge, this is the first
time such a case has been documented. We also discuss
the incidence, diagnosis, and treatment of GIST accom-
panied by PNS.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 Angiographic findings of the tumor. Angiography via
the left gastric artery showed staining of the tumor.
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A 69-year-old Asian woman was admitted to our hos-
pital because of diminished appetite. She had no previ-
ous medical history and was not complaining of fever
and, therefore, she was not taking oral non-steroid anti-
inflammatory drugs. Computed tomography revealed a
gastric tumor measuring 56 × 55mm, accompanied by
calcification (Figure 1). Angiography via her left gastric
artery showed staining of the tumor (Figure 2), and
endoscopic ultrasonography demonstrated a heteroge-
neous lesion 60mm in diameter, arising in the posterior
wall of the stomach (Figure 3). Laboratory examinations
revealed hypoproteinemia (4.8g/dL; normal range, 6.5 to
8.0), hypoalbuminemia (2.2g/dL; normal range, 3.8 to
5.3), and severe proteinuria (8.47g/dL; normal range, 0
to 0.15), and her protein creatinine ratio was 14.3g/g
and amount of urine for 24 hours was 1200mL, clinically
suggesting nephrotic syndrome. Therefore, to avoid an
invasive inspection, a kidney biopsy was not carried out.
There were no neurologic symptoms or skin disease.
Despite albumin administration, her hypoalbuminemia
did not improve preoperatively. She was given a diagnosis
of GIST of the stomach accompanied by nephrotic
syndrome, and partial gastrectomy was performed.
Macroscopically, a well-demarcated, hard, whitish sub-
mucosal tumor arose from the gastric wall (Figure 4a);
histological and immunohistochemical examinations
revealed a spindle-cell tumor positive for CD34 and c-
kit (Figure 4b, 4c), and a GIST was diagnosed.
Her postoperative course was uneventful. One week
after her operation, her serum albumin (3.3g/dL) and
urinary protein (1.71g/dL) levels remarkably improved
after removal of the tumor. She remains well with no re-
currence of the tumor or nephrotic syndrome (her recent
urinary protein level: 1.19mg/mL) 2 years after surgery.Stomach
Tumor
Figure 1 Computed tomographic findings of the tumor. A
computed tomographic scan showing a large tumor measuring
56 × 55mm accompanied by calcification. An arrow indicates the
tumor; the arrow head indicates the stomach.Discussion
Nephrotic syndrome can occur as malignancy-associated
PNS, and previous studies have estimated that cancer
occurs in 11% to 22% of patients with nephrotic syn-
drome [2,6,7]. Therefore, if an adult presents with neph-
rotic syndrome, physicians should bear in mind the risk
of underlying malignant disease. Gastric cancer, lung
cancer, and malignant lymphoma are frequently associ-
ated with nephrotic syndrome of which the rates are 25,
15 and 10%, respectively [8]. To the best of our know-
ledge, GIST has not been previously reported as anFigure 3 Endoscopic ultrasonographic findings of the tumor.
Endoscopic ultrasonography demonstrated a heterogeneous lesion
60mm in diameter, arising in the posterior wall of the stomach.
Figure 4 Pathological findings of the tumor. (a) Macroscopically, the tumor appeared to be gray-whitish and hard and arose from the gastric
wall. (b,c) Both CD34 and c-kit were positive on immunohistochemical staining.
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to be documented.
In patients with PNS, surgical tumor removal can be
followed by the regression of nephrotic syndrome. One
study reported that nephrotic syndrome improved after
operation in 78% of patients [4]. Therefore, surgical re-
section should be performed even in the presence of
poor general condition due to PNS, because cancer is a
potential cause of nephrotic syndrome [9]. The hypoalbu-
minemia and proteinuria in our patient did not preopera-
tively respond to symptomatic treatment. By contrast,
clinical remission of nephrotic syndrome was obtained im-
mediately after tumor removal. Considering that the patient
did not take drugs perioperatively which cause nephrotic
syndrome, such as non-steroidal anti-inflammatory drugs
or tyrosine kinase inhibitors, the nephrotic syndrome was
PNS associated with a GIST of the stomach.
Hypothetical explanations have been proposed to link
minimal-change glomerulopathy to solid tumors. One po-
tential mechanism involves the secretion of some tumoral
factor that increases glomerular permeability without af-
fecting glomerular capillary structure, resulting in massive
proteinuria. Alternatively, tumor-specific antigens such as
carcinoembryonic antigens may react with antibodies to
form immune complexes, which accumulate as deposits
in the glomerular basement membrane and cause renaldysfunction. The mechanism of this phenomenon can in-
volve type III allergy [10].
In summary, we have documented a case of GIST of
the stomach that was associated with nephrotic syn-
drome as PNS. Patients with refractory nephrotic syn-
drome caused by a malignant tumor should be treated
aggressively to improve signs and symptoms associated
with PNS. Otherwise, the opportunity for potentially
curative surgery may be lost.Conclusions
Nephrotic syndrome caused by GISTs is quite rare, and
to the best of our knowledge this is the first time that
such a case has been documented. Patients with refrac-
tory nephrotic syndrome caused by a malignant tumor
should be treated aggressively, even if they are in poor
general condition. Otherwise, the opportunity for poten-
tially curative surgery may be missed.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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